0.98 USD
▲-0.01+7.85%
2026-08-03
市值
$4.47M
市盈率
—
EPS
-85.53
股息率
—
52 周区间
0.84 – 309.12
成交量
268.90K
Beta
-0.24
目标价
—
52W 低 0.8452W 高 309.12
价格走势
公司简介
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research a...